Skip to main navigation
Skip to search
Skip to main content
Sort by
Pharmacology, Toxicology and Pharmaceutical Science
Acinetobacter
17%
Acinetobacter Baumannii
29%
Adalimumab
18%
Adverse Event
84%
Anti-Inflammatory Drug
27%
Antibiotic Prophylaxis
17%
Antibiotic Resistance
76%
Antibiotics
100%
Antiinfective Agent
58%
Antimicrobial Agent
62%
Antimicrobial Resistance
20%
Antioxidant
25%
Bacterium
22%
Cefazolin
24%
Cohort Study
29%
Community Pharmacy
17%
Comorbidity
34%
COVID-19 Vaccine
42%
Cross-Sectional Study
39%
Cross-Sectional Study
22%
Diabetes Mellitus
92%
Diseases
54%
Drug Interaction
36%
Drug Resistance
20%
Epidemiology
19%
Escherichia coli
20%
Etanercept
21%
FDA Adverse Event Reporting System
47%
Gentamicin
18%
Hemoglobin A1c
34%
Infection
46%
Inflammation
18%
Inflammatory Arthritis
38%
Klebsiella pneumoniae
35%
Pharmaceutical Care
16%
Pharmacotherapy
41%
Pharmacovigilance
25%
Polypharmacy
32%
Prevalence
44%
Protective Agent
18%
Quinolone Derivative
17%
Retrospective Study
26%
Rheumatoid Arthritis
38%
Side Effect
37%
Surgical Infection
42%
Surgical Prophylaxis
34%
Thromboembolism
16%
Transcription Factor Nrf2
32%
Vaccination
24%
Warfarin
42%
Nursing and Health Professions
Adherence
17%
Adverse Event
26%
Antiinfective Agent
18%
Antimicrobial Resistance
16%
Antimicrobial Stewardship
33%
Chronic Condition
40%
Chronic Disease
18%
Cohort Analysis
21%
Colistimethate
8%
Combination Therapy
8%
Comorbidity
10%
Confidence Interval
25%
Congestive Heart Failure
16%
COVID-19
16%
Cross-Sectional Study
62%
Cross-Sectional Study
15%
Diabetes Mellitus
32%
Diseases
52%
Drug Therapy
8%
Education
9%
Food and Drug Administration
8%
Gentamicin
12%
Health Care Cost
16%
Health Care Personnel
34%
Hemoglobin A1c
8%
Hospital Discharge
8%
Hypertension
12%
Infection
11%
Inflammatory Arthritis
18%
Logistic Regression Analysis
10%
Medication Error
10%
Meta Analysis
9%
Methotrexate
16%
Odds Ratio
24%
Orphan Drug
16%
Patient Care
19%
Patient Compliance
16%
Perioperative
16%
Pharmacy Student
8%
Polypharmacy
22%
Practice Guideline
20%
Prevalence
24%
Primary Health Care
33%
Quality of Life
8%
Rheumatoid Arthritis
18%
Saudi Arabia
99%
Side Effect
8%
Surgical Infection
24%
Telemedicine
32%
Tertiary Care Center
16%
Medicine and Dentistry
Acinetobacter
8%
Acinetobacter Baumannii
8%
Acute Coronary Syndrome
8%
Antibiotic Resistance
34%
Antibiotics
19%
Anticoagulant
8%
Antimicrobial Agent
10%
Awareness
8%
Azoospermia
8%
Biological Response Modifier
16%
Cardiovascular System
16%
Cardiovascular System
8%
Cell Therapy
8%
Cohort Analysis
8%
Combination Therapy
9%
Comorbidity
16%
COVID-19 Vaccination
8%
Cross Sectional Study
12%
Culture Conversion
11%
DAS28
9%
Diabetes Mellitus
32%
Diseases
28%
Distress Syndrome
8%
Drug Resistant Tuberculosis
16%
Drug Therapy
17%
Education
10%
Educational Intervention
8%
Foreign Body
16%
Gene Therapy
8%
Health Care Cost
16%
Health Technology
8%
Hemoglobin A1c
8%
Klebsiella pneumoniae
18%
Multiple Sclerosis
8%
Pharmaceutical Care
8%
Pneumomediastinum
16%
Pneumonia
16%
Pneumothorax
16%
Prevalence
8%
Primary Health Care
8%
Quality of Life
18%
Sputum Culture
11%
Sputum Smear
16%
Systematic Review
8%
Technology Assessment
8%
Telemedicine
8%
TNF Inhibitor
12%
Univariate Analysis
8%
Vaccine Hesitancy
8%
Warfarin
8%